SINOMAB BIO-B

3681
0.9600.52% ( +0.005 )
Delay Closed: Nov 16, 16:08:11

Financials

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: SINOMAB BIO-B(03681) the EBIT is -51.6 M (-66.77%);the EPS is -0.0537 (-115.5%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.05B66.77%
----
----
EPS
-0.0537115.51%
----
----

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateDec 1, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly